Women with good exercise capacity have a lower risk of death Beauty and convenience in one product
BASED on a new study carried out by researchers at the University Hospital A Coruña, in Spain, a vigorous exercise routine could significantly lower a woman’s risk of death from heart disease, cancer and other causes.
The new study looked at 4,714 adult women who were referred for a treadmill exercise echocardiography because they had or were suspected to have coronary artery disease.
The treadmill exercise echocardiography involves walking or running on a treadmill as the intensity gradually increases until the participants reach exhaustion. During the test, images were also taken of the participants’ heart.
The participants’ fitness levels were defined using Metabolic Equivalent of Task (MET) minutes per week (MET-mins/week). MET measures an individual’s energy expenditure, with one MET defined as the energy it takes to sit quietly. Moderate-intensity activities burn around 3 to 6 METs, and vigorous-intensity activities burn more than 6 METs.
In this study, women who achieved 10 METs or more were defined as having a good exercise capacity compared to women who achieved less than 10 METs, who were defined as having a poor exercise capacity.
The findings, which were presented at the recent EuroEcho 2019, a scientific congress of the European Society of Cardiology (ESC) showed that after taking into account possibly influencing factors, METs were significantly associated with a lower risk of death from cardiovascular disease, cancer, and other causes.
More specifically, the annual rate of death from cardiovascular disease was nearly four times higher in women with poor exercise capacity, compared to those with good, (2.2% versus 0.6%), and annual cancer deaths were doubled in patients with poor, compared to good, exercise capacity (0.9% versus 0.4%). The annual rate of death from other causes was more than four times higher in those with poor, compared to good, exercise capacity (1.4% vs. 0.3%).
After looking at the images taken of the participants’ hearts, the researchers also found that patients with poor heart function during exercise had a higher risk of death from cardiovascular disease during follow-up, although heart function during exercise was not linked with the risk of death from cancer or other causes.
Study author Dr. Jesús Peteiro commented on the findings by advising women to “exercise as much as you can. Fitness protects against death from any cause.”
“Looking at both examinations together, women whose heart works normally during exercise are unlikely to have a cardiovascular event. But if their exercise capacity is poor, they are still at risk of death from cancer or other causes. The best situation is to have normal heart performance during exercise and good exercise capacity,” said Dr. Peteiro. – AFPRelaxnews
UNLOCK your potential for beautiful skin with MF3 BLUECELL Extracts AF2. This revolutionary formula is a 3-in-1 face moisturiser serum gel, eye gel and neck gel. This simplicity is borne through the regenerative powers from the deep blue combined with Oxygenin.
This innovative blend of liquid oxygen and marine and botanical plants extracts is the secret behind BLUECELL Extracts AF2’s ability to saturate the skin cells with moisture, and boost the skin’s natural radiance and resilience against photo-ageing and environmental stress.
Does your skin feel dry, and dull with more visible fine lines and wrinkles? Those are the signs of skin lacking in moisture and also due to ageing which occurs over time or is accelerated by sunlight exposure and unhealthy lifestyle factors.
If you notice your skin is itchy, feels scaly, and shows redness or blisters, then you may have skin inflammation. That’s the result of your body’s immune system reacting to certain triggers such as allergies, infections and
Three in 10 Americans are thought to have metabolic syndrome. To ward it off, doctors have little to offer beyond exercising more, eating less and losing weight. But patients often ignore or abandon that medical advice and go on to develop full-blown type 2 diabetes.
In the pilot study, the participants limited their “eating day” to under 11 hours for 12 weeks. They reduced their calorie intake by almost nine per cent, lost an average of three per cent of their body weight, and reported more restful sleep - all improvements that could aid in disrupting a patient’s progression from metabolic syndrome to diabetes.
As a group, participants reduced their belly fat - a bellwether of future heart disease risk - by three per cent.
Drilling down on the physiological effects of a daily 14-hour fast, researchers also found a wide range of subtler improvements among the 19 subjects.
The group’s blood pressure, typically high in those with pre-diabetes, fell. Their cholesterol readings, typically worrisome in this population, improved. And in the 12 participants whose metabolic function had already veered into abnormal territory, three months of time-restricted eating appeared to bring about improvements.
These changes came about without any increase in participants’ physical activity. And improvements didn’t rise or fall with changes in weight. Time-restricted eating did induce weight loss, which typically improves many bodily functions. But it appeared to effect key changes in direct ways, rather than just by helping subjects slim down.
In several cases, participants were able to discontinue or take smaller doses of medications, such as cholesterol-lowering statins or hypertension drugs. In other instances, researchers saw that shortening their eating day and observing a long nightly fast helped patients who were not sufficiently helped by medication alone to achieve normal readings.
The results were published in the journal Cell Metabolism.
None of these promising findings is definitive: With only 19 participants and no control group, the work merely lays the foundation for further investigation.
But a much larger clinical trial that meets the gold standard of biomedical research is already in the works. Underwritten by the National Institute of Diabetes and Digestive and Kidney Diseases, that trial will also explore the benefits of daily fasting in people with metabolic syndrome. diseases.
BLUECELL Extracts AF2 is an innovation arising from our Skin Health Cosmeceutical Science partners in Germany and the United States, who are winners of the prestigious 2001 Crystal Award.
This cellular moisturising serum gel dissolves deep into the skin where it works its wonders from within. It delivers oxygen and nutrients to the skin cells, and provides ample skin hydration. This helps to accelerate wound healing, reduce fine lines and wrinkles, and support elastin and collagen production and maintenance.
The long-lasting hydration makes for healthy and supple skin. BLUECELL Extracts AF2 soothes and nourishes the skin as part of its daily moisturising and repair activity. It combines the rich cellular nutrients of blue plants, marine DNA elements and several other bioactive botanical extracts and essential lipids for rejuvenation of the face, eye and neck.
This article is brought to you by NXG Global Sdn Bhd. For more information, call 017-802 9133 or email: sales@mf3.com.my.
Bluecell Extracts AF2 (NOT171104518K)